As high levels of Bcl-2 may indicate that downstream apoptotic pathways are still functional and can be a marker of chemosensitivity and favorable prognosis in certain cancers [19], it is not surprising BCL2 abnormality did not have a prognostic role for MCL in this study. This evidence concerns the gene BCL2 and mantle cell lymphoma.